Swiss National Bank Deciphera Pharmaceuticals, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$13.58 - $17.36 $17,654 - $22,568	1,300 Added 1.86%	71,200 $1.12 Million
Q4 2023 Feb 06, 2024	SELL	$10.11 - $16.54 $166,815 - $272,910	-16,500 Reduced 19.1%	69,900 $1.13 Million
Q3 2023 Nov 08, 2023	SELL	$12.46 - $15.48 $252,938 - $314,244	-20,300 Reduced 19.03%	86,400 $1.1 Million
Q2 2023 Aug 09, 2023	SELL	$13.28 - $15.96 $79,680 - $95,760	-6,000 Reduced 5.32%	106,700 $1.5 Million
Q1 2023 May 10, 2023	BUY	$14.26 - $22.1 $226,734 - $351,390	15,900 Added 16.43%	112,700 $1.74 Million
Q4 2022 Feb 08, 2023	BUY	$14.85 - $19.04 $38,610 - $49,504	2,600 Added 2.76%	96,800 $1.59 Million
Q3 2022 Nov 09, 2022	BUY	$12.38 - $20.23 $141,132 - $230,622	11,400 Added 13.77%	94,200 $1.74 Million
Q2 2022 Aug 09, 2022	SELL	$9.11 - $13.98 $127,539 - $195,720	-14,000 Reduced 14.46%	82,800 $1.09 Million
Q1 2022 May 09, 2022	BUY	$6.87 - $11.11 $49,464 - $79,992	7,200 Added 8.04%	96,800 $897,000
Q3 2021 Nov 08, 2021	BUY	$26.46 - $37.15 $18,522 - $26,005	700 Added 0.79%	89,600 $3.05 Million
Q2 2021 Aug 06, 2021	BUY	$32.73 - $47.95 $140,739 - $206,185	4,300 Added 5.08%	88,900 $3.26 Million
Q1 2021 May 07, 2021	BUY	$40.39 - $56.73 $68,663 - $96,441	1,700 Added 2.05%	84,600 $3.79 Million
Q4 2020 Feb 05, 2021	BUY	$51.77 - $66.18 $31,062 - $39,708	600 Added 0.73%	82,900 $4.73 Million
Q3 2020 Nov 09, 2020	BUY	$43.8 - $58.16 $157,680 - $209,376	3,600 Added 4.57%	82,300 $4.22 Million
Q2 2020 Aug 05, 2020	BUY	$37.05 - $65.03 $1.08 Million - $1.9 Million	29,200 Added 58.99%	78,700 $4.7 Million
Q1 2020 May 08, 2020	BUY	$33.63 - $69.4 $87,438 - $180,440	2,600 Added 5.54%	49,500 $2.04 Million
Q4 2019 Feb 06, 2020	BUY	$31.7 - $69.93 $38,040 - $83,916	1,200 Added 2.63%	46,900 $2.92 Million
Q3 2019 Nov 12, 2019	BUY	$19.95 - $38.85 $420,945 - $819,735	21,100 Added 85.77%	45,700 $1.55 Million
Q2 2019 Aug 02, 2019	SELL	$21.05 - $26.21 $58,940 - $73,388	-2,800 Reduced 10.22%	24,600 $555,000
Q1 2019 May 10, 2019	BUY	$20.65 - $29.55 $16,520 - $23,640	800 Added 3.01%	27,400 $636,000
Q4 2018 Feb 13, 2019	BUY	$19.08 - $36.14 $17,172 - $32,526	900 Added 3.5%	26,600 $558,000
Q2 2018 Aug 09, 2018	BUY	$20.06 - $44.95 $515,541 - $1.16 Million	25,700 New	25,700 $1.01 Million

Others Institutions Holding DCPH

# of Institutions

Shares Held

293K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account